We are live on ! Find out more
TNGX icon

Tango Therapeutics
TNGX

121 hedge funds and large institutions have $929M invested in Tango Therapeutics in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 42 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

131% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 16

100% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 21

21% more funds holding

Funds holding: 100 → 121 (+21)

4.66% more ownership

Funds ownership: 87.3% → 91.96% (+4.7%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

7% less capital invested

Capital invested by funds: $1,000M → $929M (-$71.3M)

Holders
121
Holders Change
+21
Holders Change %
+21%
% of All Funds
1.76%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
37
Increased
42
Reduced
21
Closed
16
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$5K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$40M
2
RI
RTW Investments
New York
+$17.1M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$14.3M
4
BC
Boxer Capital
California
+$9.33M
5
DM
Deerfield Management
New York
+$6.48M

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$25M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.1M
3
PA
Perceptive Advisors
New York
-$11.3M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.51M
5
SCM
Soleus Capital Management
Connecticut
-$9.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$4.08M +$95.2K +10,963 +3%
Charles Schwab
27
Charles Schwab
California
$3.65M +$14.8K +1,709 +0.5%
AAA
28
Affinity Asset Advisors
New York
$2.97M -$432K -49,726 -14%
Millennium Management
29
Millennium Management
New York
$2.92M +$2.56M +294,558 New
Morgan Stanley
30
Morgan Stanley
New York
$2.84M +$812K +93,490 +48%
T. Rowe Price Investment Management
31
T. Rowe Price Investment Management
Maryland
$2.84M +$2.49M +286,694 New
Two Sigma Investments
32
Two Sigma Investments
New York
$2.34M +$905K +104,301 +79%
Barclays
33
Barclays
United Kingdom
$2M +$990K +114,017 +130%
Citadel Advisors
34
Citadel Advisors
Florida
$2M +$1.75M +201,815 New
TCM
35
Tang Capital Management
California
$1.98M – – –
Connor, Clark & Lunn Investment Management (CC&L)
36
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.79M +$1.4M +161,177 +830%
Wellington Management Group
37
Wellington Management Group
Massachusetts
$1.69M +$777K +89,481 +111%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$1.4M -$119K -13,705 -9%
Renaissance Technologies
39
Renaissance Technologies
New York
$1.2M +$719K +82,800 +217%
Voloridge Investment Management
40
Voloridge Investment Management
Florida
$1.13M +$993K +114,357 New
CSS
41
Cubist Systematic Strategies
Connecticut
$1M +$880K +101,332 New
Fisher Asset Management
42
Fisher Asset Management
Washington
$997K +$874K +100,691 New
Squarepoint
43
Squarepoint
New York
$988K +$866K +99,808 New
Jane Street
44
Jane Street
New York
$854K +$748K +86,224 New
Swiss National Bank
45
Swiss National Bank
Switzerland
$794K -$168K -19,300 -19%
Victory Capital Management
46
Victory Capital Management
Texas
$719K +$631K +72,640 New
American Century Companies
47
American Century Companies
Missouri
$697K +$405K +46,691 +197%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$697K +$5.42K +624 +0.9%
PHP
49
Parkman Healthcare Partners
Connecticut
$650K -$610K -70,241 -52%
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
$621K – – –
1
2
3 4 5

TNGX Hedge Fund Activity: Q4 2023 in Review

121 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q4 2023, worth a combined $929M — down 7.1% from $1,000M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new TNGX positions and 16 closed out — a net gain of 21 holders — while 42 added to existing stakes and 21 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $40M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $25M sold.

  • 121 institutional investors held Tango Therapeutics (TNGX) as of Q4 2023, up from 100 in Q3 2023.
  • Funds reported $929M of Tango Therapeutics stock for Q4 2023, down 7.1% quarter-over-quarter.
  • 37 funds opened new Tango Therapeutics positions in Q4 2023 and 16 closed out, a net change of +21 holders.
  • The largest Tango Therapeutics buyer in Q4 2023 was EcoR1 Capital, an estimated $40M added.
  • The largest Tango Therapeutics seller in Q4 2023 was Avoro Capital Advisors, an estimated $25M sold.

Based on aggregated 13F filings for Q4 2023.